Status: Recruiting
Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders
Autologous platelet rich plasma (PRP) intraovarian infusion may improve ovarian response to controlled ovarian stimulation as well as the hormonal profile of poor ovarian response infertile women subjected to intracytoplasmic sperm injection (ICSI) treatment.
Participants needed: 100
Trial details
Phase: Phase 2, Phase 3Age: 35-47Biological sex: FemaleType: InterventionalSponsor: Genesis Athens ClinicUpdated: Dec 27, 2024Locations: 1
Eligibility criteria
Age ≥ 40 years [+4]
Any pathological disorder related to reproductive system anatomy [+13]